Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
3D Medicines (Sichuan) Co., Ltd.
Sichuan, China
- Ownership
- Private
- Development stage
- Other
01
Overview
3D Medicines is a commercial-stage oncology company with a leading PD-L1 monoclonal antibody (envafolimab) approved in China and a diverse late-stage pipeline including radiopharmaceuticals, mRNA cancer vaccines, and combination immunotherapies. Envafolimab showed rapid registration (NDA in <4 years after phase I) and is approved for MSI-H/dMMR advanced solid tumors. Pipeline assets address multiple solid tumor indications with both mono and combo strategies, and early radiopharmaceutical/mRNA platforms are in preclinical and early clinical development.[1][2][3][5][7]
- Therapeutic areas
- Oncology
- Modalities
- Monoclonal antibodySmall moleculemRNA-based drugsRadiopharmaceuticalNanobodyAntibody-drug conjugate
- Industry
- Biotech
02
Partnerships
External production and sales partnerships for commercializationOverseas regulatory and clinical collaborations
Beyond the preview
Go deeper on 3D Medicines (Sichuan) Co., Ltd..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 3D Medicines (Sichuan) Co., Ltd..